Violich Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-3,100
| Closed | -$226K | – | 114 |
|
2019
Q3 | $226K | Sell |
3,100
-140
| -4% | -$10.2K | 0.05% | 101 |
|
2019
Q2 | $266K | Hold |
3,240
| – | – | 0.07% | 100 |
|
2019
Q1 | $229K | Buy |
+3,240
| New | +$229K | 0.06% | 104 |
|
2018
Q3 | – | Sell |
-4,520
| Closed | -$302K | – | 117 |
|
2018
Q2 | $302K | Buy |
4,520
+680
| +18% | +$45.4K | 0.08% | 93 |
|
2018
Q1 | $224K | Sell |
3,840
-300
| -7% | -$17.5K | 0.06% | 101 |
|
2017
Q4 | $267K | Hold |
4,140
| – | – | 0.07% | 96 |
|
2017
Q3 | $217K | Buy |
+4,140
| New | +$217K | 0.06% | 104 |
|
2017
Q1 | – | Sell |
-4,020
| Closed | -$255K | – | 111 |
|
2016
Q4 | $255K | Buy |
4,020
+120
| +3% | +$7.61K | 0.08% | 92 |
|
2016
Q3 | $259K | Hold |
3,900
| – | – | 0.09% | 83 |
|
2016
Q2 | $218K | Buy |
+3,900
| New | +$218K | 0.07% | 90 |
|